🔎 Trials Near Me

መነሻ › የእንቁላል ካንሰር › ኢሊኖይ › Chicago

በChicago፣ IL ለየእንቁላል ካንሰር የሚደረጉ ክሊኒካዊ ጥናቶች

ለየእንቁላል ካንሰር የሚደረጉ 36 ጥናቶች በChicago እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።

Official study text (English)

ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Research Site, Chicago
እድሜ ከ18 እስከ 130 · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦክቶ 2026 · NCT05417594

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

ተሳታዮችን በመፈለግ ላይደረጃ 2/3
  • Northwestern University, Chicago
  • University of Chicago Comprehensive Cancer Center, Chicago
  • Northwestern Medicine Cancer Center Old Irving Park, Chicago
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦክቶ 2026 · NCT07001748

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Mount Sinai Hospital Medical Center, Chicago
  • Northwestern University, Chicago
  • John H Stroger Jr Hospital of Cook County, Chicago
  • እና 3 ተጨማሪ
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦክቶ 2026 · NCT05564377

A Study of PHST001 in Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • University of Chicago Medical Center, Chicago
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦክቶ 2026 · NCT06840886

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • University of Chicago Hospital, Chicago
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT06465069

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • University of Illinois Cancer Center, Chicago
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT06172478

A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • University of Chicago Medical Center /ID# 278295, Chicago
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ30 ሴፕቴ 2026 · NCT07278336

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • University of Chicago, Chicago
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ29 ሴፕቴ 2026 · NCT05051722

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Rush Md Anderson Cancer Center /ID# 274926, Chicago
  • University of Chicago Medical Center /ID# 274796, Chicago
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ29 ሴፕቴ 2026 · NCT06890338

A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
  • University of Chicago Medical Center, Chicago
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ24 ሴፕቴ 2026 · NCT04590326

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Northwestern Memorial Hospital, Chicago
  • Rush University Medical Center, Chicago
  • The University of Chicago Medicine, Chicago
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07213804

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Northwestern University Feinberg School of Medicine, Chicago
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ21 ሴፕቴ 2026 · NCT05983432

Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • The University of Chicago Medicine, Chicago
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ15 ሴፕቴ 2026 · NCT07214779

Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • University of Chicago, Chicago
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ14 ሴፕቴ 2026 · NCT06787612

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • University of Illinois Cancer Center, Chicago
  • University of Chicago Medicine, Chicago
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ10 ሴፕቴ 2026 · NCT06293898

Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • University of Chicago, Chicago
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ8 ሴፕቴ 2026 · NCT04107077

Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • University of Chicago Medical Center, Chicago
እድሜ 15 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT06276491

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Lurie Children's Hospital-Chicago, Chicago
12 Months – 30 Years · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT04851119

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

ተሳታዮችን በመፈለግ ላይ
  • Northwestern University, Chicago
  • Rush MD Anderson Cancer Center, Chicago
  • University of Illinois, Chicago
  • እና 2 ተጨማሪ
እድሜ ከ35 እስከ 50 · ሴቶች · የተሻሻለው በ7 ኦገስ 2026 · NCT04251052

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • John H Stroger Jr Hospital of Cook County, Chicago
  • University of Illinois, Chicago
  • University of Chicago Comprehensive Cancer Center, Chicago
  • እና 1 ተጨማሪ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ7 ኦገስ 2026 · NCT06580314

A Trial to Evaluate Safety, Tolerability, and Preliminary Efficacy of Misetionamide (GP-2250) as Monotherapy or in Combination With Gemcitabine

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Rush University Medical Center, Chicago
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ23 ጁላይ 2026 · NCT03854110

Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • The University of Chicago Medical Center, Chicago
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ21 ጁላይ 2026 · NCT04918186

An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Northwestern Memorial Hospital, Chicago
እድሜ ከ18 እስከ 100 · ሴቶች · የተሻሻለው በ13 ጁላይ 2026 · NCT05887609

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • UChicago Medicine - River East, Chicago
  • The University Of Chicago, Chicago
  • University of Chicago Medical Center, Chicago
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ6 ጁላይ 2026 · NCT04389632

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Northwestern University, Chicago
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ29 ጁን 2026 · NCT05377996

A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Northwestern Memorial Hospital, Chicago
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ4 ጁን 2026 · NCT04300556

Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)

ተሳታዮችን በመፈለግ ላይ
  • Northwestern University, Chicago
እድሜ 60 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ29 ሜይ 2026 · NCT05743517

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • University of Chicago Medical Center, Chicago
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ13 ሜይ 2026 · NCT03686124

TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention

ተሳታዮችን በመፈለግ ላይ
  • UChicago Medicine, Chicago
እድሜ ከ25 እስከ 50 · ሴቶች · የተሻሻለው በ6 ኤፕሪ 2026 · NCT04294927

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • University of Chicago Medical Center, Chicago
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ27 ማርች 2026 · NCT06395519

Alternate Day Fasting After Surgery for Patients Undergoing Chemotherapy

ተሳታዮችን በመፈለግ ላይ
  • Northwestern Memorial Hospital, Chicago
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ24 ማርች 2026 · NCT05990426

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • The University of Chicago Comprehensive Cancer Center, Chicago
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ13 ፌብሩ 2026 · NCT06778863

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • University of Chicago Medical Center, Chicago
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ23 ዲሴም 2025 · NCT06690775

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Massive Bio SYNERGY-AI site, Chicago
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ28 ኦክቶ 2025 · NCT03452774

Specimen and Data Study for Ovarian Cancer Early Detection and Prevention

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
  • Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago
እድሜ ከ18 እስከ 80 · ሴቶች · የተሻሻለው በ28 ፌብሩ 2025 · NCT00005095

CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Northwestern University, Chicago
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ10 ማርች 2023 · NCT05733000

በሌሎች ከተሞች ለየእንቁላል ካንሰር የሚደረጉ ጥናቶች

በChicago ውስጥ ያሉ ሌሎች ጥናቶች

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።